A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

FDA Acts Against Company Selling Products With Fraudulent COVID-19 Claims

By Kristen Pratt Machado On Sep 11, 2020

The United States Food and Drug Administration (FDA) issued a warning letter on September 10 to Pharmacy Plus Inc for fraudulently claiming its products are helpful against COVID-19. The company makes “COVID PACK” and “COVID ‘POSITIVE’ PACK,” which make claims that these products “mitigate, prevent, treat, diagnose, or cure COVID-19.” The FDA asked the company to immediately remove these products from consumer shelves, and asserts that there are currently no products approved for the treatment or prevention of COVID-19. Click here to read more.

Kristen Pratt Machado

Kristen Pratt Machado is executive editor for Dimensions of Dental Hygiene and Decisions in Dentistry and director of publishing operations for Belmont Publications, Inc. She has been with Belmont Publications since its inception in 2002.

UV Angel Announces Two New UV-C Light Products to Neutralize Pathogens on Surfaces and in the Air

University of Kentucky’s College of Dentistry Continues Outreach Progress, Despite COVID-19